FOLD Financial Facts
Loss from operations: -44.94MNet loss: -46.65M
See Full Income Statement
Additional paid-in capital: 1.04B
Total current assets: 221.71M
See Full Balance Sheet
Amicus Therapeutics, Inc. (FOLD) Earnings
|
Expand Research on FOLD
| Next EPS Date | 5/7/24 | EPS Growth Rate | +66.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.1% | Revenue Growth Rate | +30.2% |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/15  |
 |
Q215 | -$0.27 | -$0.24 | -$0.03 | N/A | $130K | N/A |  | | Details |
| 11/8/17 | |
Q317 | -$0.41 | -$0.31 | -$0.10 | $10.9M | $9.52M | = | | | Details |
| 2/28/24 | Q423 | $0.01 | -$0.06 | +$0.07 | $115.08M | $114.35M | N/A | | | Details | |
| 5/8/19 | |
Q119 | -$0.56 | -$0.31 | -$0.25 | $34M | $37.86M | = | | | Details |
| 8/7/17 | |
Q217 | -$0.34 | N/A | N/A | $7.2M | $4.2M | = | | | Details |
| 8/8/23 | Q223 | -$0.15 | -$0.11 | -$0.04 | $94.5M | $89.83M | N/A | | | Details | |
| 11/5/18 | |
Q318 | -$0.84 | -$0.28 | -$0.56 | $20.6M | $23.57M | = | | | Details |
| 5/10/23 | Q123 | -$0.18 | -$0.14 | -$0.04 | $86.3M | $83.07M | N/A | | | Details |
